According to Benzinga Pro, Charles River Laboratories International Inc's peer group average for short interest as a ...

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP). Launched in December 2024, with the inaugural cohort ...

Charles River Laboratories International Inc. has announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP).

The Covid-19 pandemic brought rare disease research to a standstill. Five years later, patients and advocates say the ...

Autobahn Labs signs partnership with Astellas Pharma to speed up academic discoveries into novel medicines: Palo Alto, California Saturday, December 13, 2025, 10:00 Hrs [IST] Auto ...

The "Pharmaceutical Safety Assessment Global Market Report 2025" has been added to ResearchAndMarkets.com's offering.The pharmaceutical safety assessment market has demonstrated significant growth, ...

DaVita, a leading provider of kidney care services, today announced two key additions to its executive leadership team: Stephanie Hendrickson has been named Chief People Officer (CPO) and Steve ...

Christie Innomed Inc., a leader in medical imaging and health technologies, announces that Dr. Michel Vachon and Nicolas Vachon have acquired all the shares of Group Christie and its subsidiaries.

Agora Open Science Trust today announced the nomination of M4K2009 as the lead development candidate for its M4K Pharma ...

Prominent companies operating in the global drug discovery services market include: • Charles River Laboratories (US) • ...

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face ...